State Drug Price Transparency: Turning a Patchwork of Mandates into a Scalable Compliance Strategy

Move beyond reactive reporting with a scalable approach to state drug price transparency.

What was once an occasional reporting obligation has become an ongoing operational and compliance risk.

In this on-demand webinar, Erica Petersohn explores how manufacturers can move beyond reactive, manual approaches and adopt a scalable, sustainable compliance strategy for state drug price transparency. Gain practical insight into common regulatory triggers, the cost of non-compliance, and operational pitfalls that lead to missed or inconsistent filings. You'll also discover best practices for centralizing data, improving cross-functional coordination, and building repeatable processes that can adapt as state requirements continue to evolve.

You'll learn how to:

• Understand the latest state transparency requirements
• Identify common reporting triggers and compliance risks
• Avoid operational gaps that lead to missed filings
• Improve cross-functional coordination
• Centralize compliance data and regulatory intelligence
• Build scalable, repeatable reporting processes